18
Participants
Start Date
August 31, 2010
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
PF-04308515
10 mg extemporaneous preparation of oral solution predosed 8 hours prior to Oral Glucose Tolerance Test(OGTT)
PF-04308515
10 mg extemporaneous preparation of oral solution predosed 12 hours prior to Oral Glucose Tolerance Test(OGTT)
Prednisone
5 mg tablet predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)
PF-04308515
X mg of Pf-04308515 extemporaneous oral solution predosed at selected time from Part 1 prior to Oral Glucose Tolerance Test (OGTT)
PF-04308515
Y mg of Pf-04308515 extemporaneous oral solution predosed at selected time from Part 1 prior to Oral Glucose Tolerance Test (OGTT)
Prednisone
5 mg tablet predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)
Prednisone
20 mg (5 mg tablets) predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)
Pfizer Investigational Site, Kalamazoo
Lead Sponsor
Pfizer
INDUSTRY